NCT00132730: An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005) |
|
|
| Terminated | 2 | 604 | NA | MK-0873 2.5 mg, MK-0873 1.25 mg, MK-0873 0.75 mg, Placebo to MK-0873, Usual Care | Merck Sharp & Dohme LLC | Lung Diseases, Pulmonary Disease, Chronic Obstructive | 08/05 | 08/05 | | |
